Fennec Pharmaceuticals Inc. (FENC) vs Ocugen, Inc. (OCGN)

A side-by-side comparison of Fennec Pharmaceuticals Inc. and Ocugen, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — FENC vs OCGN

growth of $100 · dividends reinvested · last 9y
FENC -11.5% (-1.3%/yr)OCGN -99.2% (-41.4%/yr)FENC compounded faster over this window
Log scale — wide-divergence pair
01101001kStart $1002019202120232025$89$1
FENC OCGN

FENC vs OCGN: by the numbers

  • •FENC is the larger company ($358M vs $358M market cap).
  • •Both run net losses; FENC's is the smaller (-5.49% vs -1786.27% net margin).

Metrics side by side

Valuation

MetricFENCOCGN
Forward P/E36.39N/A
P/S ratio6.0578.11
P/B ratio8.44N/A

Profitability

MetricFENCOCGN
Gross margin93.73%45.86%
Operating margin-14.22%-1425.70%
Net margin-5.49%-1786.27%
ROE-7.66%N/A
ROIC-1.84%-93.74%

Growth (annualized)

MetricFENCOCGN
Revenue CAGR (5Y)222.46%N/A
Total return CAGR (5Y)2.45%-31.57%

Frequently asked

How have FENC and OCGN total returns compared?
Over the past 5 years, FENC delivered 2.45% and OCGN delivered -31.57% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.